Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stijn L W Koolen

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 2, 2021
Cross-resistance and drug sequence in prostate cancerStefan A J Buck, Stijn L W Koolen, Ron H J Mathijssen, et al.
Drugs|December 28, 2020
Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and DifferencesC Louwrens Braal, Elisabeth M Jongbloed, Saskia M Wilting, et al.
Pharmaceuticals (Basel, Switzerland)|February 9, 2021
Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase InhibitorsRuben A G van Eerden, Esther Oomen-de Hoop, Aad Noordam, et al.
EJNMMI Radiopharmacy and Chemistry|February 6, 2024
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectivesEline L Hooijman, Valery Radchenko, Sui Wai Ling, et al.
Therapeutic Drug Monitoring|May 31, 2018
Development of an Enzyme-Linked Immune Sorbent Assay to Measure Nivolumab and Pembrolizumab Serum ConcentrationsEdwin A Basak, Annemarie J M Wijkhuijs, Ron H J Mathijssen, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 20, 2020
To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometryG D Marijn Veerman, Peter de Bruijn, Anne-Marie C Dingemans, et al.
Nephron. Clinical Practice|January 10, 2014
Pharmacokinetics of dalteparin during haemodialysisJeannet Nigten, Karina A de Groot, Diana C Grootendorst, et al.
Hepatology Communications|June 11, 2022
Tamoxifen use and potential effects on liver parenchyma: A long-term prospective transient elastographic evaluationC Louwrens Braal, Robert J de Knegt, Agnes Jager, et al.
Journal for Immunotherapy of Cancer|October 23, 2020
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanomaDaan P Hurkmans, Christina Jensen, Stijn L W Koolen, et al.
Frontiers in Pharmacology|April 17, 2020
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of TamoxifenLena Klopp-Schulze, Anna Mueller-Schoell, Patrick Neven, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 2, 2021
Cross-resistance and drug sequence in prostate cancerStefan A J Buck, Stijn L W Koolen, Ron H J Mathijssen, et al.
Drugs|December 28, 2020
Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and DifferencesC Louwrens Braal, Elisabeth M Jongbloed, Saskia M Wilting, et al.
Pharmaceuticals (Basel, Switzerland)|February 9, 2021
Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase InhibitorsRuben A G van Eerden, Esther Oomen-de Hoop, Aad Noordam, et al.
EJNMMI Radiopharmacy and Chemistry|February 6, 2024
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectivesEline L Hooijman, Valery Radchenko, Sui Wai Ling, et al.
Therapeutic Drug Monitoring|May 31, 2018
Development of an Enzyme-Linked Immune Sorbent Assay to Measure Nivolumab and Pembrolizumab Serum ConcentrationsEdwin A Basak, Annemarie J M Wijkhuijs, Ron H J Mathijssen, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 20, 2020
To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometryG D Marijn Veerman, Peter de Bruijn, Anne-Marie C Dingemans, et al.
Nephron. Clinical Practice|January 10, 2014
Pharmacokinetics of dalteparin during haemodialysisJeannet Nigten, Karina A de Groot, Diana C Grootendorst, et al.
Hepatology Communications|June 11, 2022
Tamoxifen use and potential effects on liver parenchyma: A long-term prospective transient elastographic evaluationC Louwrens Braal, Robert J de Knegt, Agnes Jager, et al.
Journal for Immunotherapy of Cancer|October 23, 2020
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanomaDaan P Hurkmans, Christina Jensen, Stijn L W Koolen, et al.
Frontiers in Pharmacology|April 17, 2020
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of TamoxifenLena Klopp-Schulze, Anna Mueller-Schoell, Patrick Neven, et al.
Pageof 13